Glandubolin
Brand names,
Glandubolin
Analogs
Glandubolin
Brand Names Mixture
- Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
- Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)
Glandubolin
Chemical_Formula
C18H22O2
Glandubolin
RX_link
No information avaliable
Glandubolin
fda sheet
Glandubolin
msds (material safety sheet)
Glandubolin
Synthesis Reference
G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)
Glandubolin
Molecular Weight
270.366 g/mol
Glandubolin
Melting Point
254.5-256 oC
Glandubolin
H2O Solubility
3 g/100mL
Glandubolin
State
Solid
Glandubolin
LogP
4.067
Glandubolin
Dosage Forms
Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension
Glandubolin
Indication
For management of Menopausal and postmenopausal disorders
Glandubolin
Pharmacology
Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.
Glandubolin
Absorption
43%
Glandubolin
side effects and Toxicity
Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.
Glandubolin
Patient Information
Glandubolin
Organisms Affected
Humans and other mammals